Clinical Trial Update: Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is currently enrolling by invitation to evaluate the pre-operative use of Vabysmo (faricimab) in patients with non-clearing vitreous he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy
• Vitreous Hemorrhage Due to Diabetes Mellitus

Drugs mentioned

• VABYSMO (faricimab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetic Retinopathy, Vitreous Hemorrhage Due to Diabetes Mellitus | Phase 4 | Status: ENROLLING_BY_INVITATION